Investigation of satisfaction and efficacy after switching from daily DPP-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes -prospective observational study
Phase 4
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000022858
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with malignant tumor 2)Pregnancy, nursing woman or possibly pregnant woman 3)Patients with severe infection, pre or post operation, severe trauma 4)Patients who are taking kinds of steroid 5)Patients with severe liver dysfunction(AST,ALT>100U/L) 6) Type 1 diabetes mellitus 7) Patients with hypersensitivity to study drugs on this study 8)Patients who can not do diet and exercise therapy 9)Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DTSQ(Diabetes Treatment Satisfaction Questionnaire)
- Secondary Outcome Measures
Name Time Method DTR-QOL(Diabetes Therapy Related Quality of life) HbA1c Plasma glucose Weight Frequency of hypoglycemia Stratified analysis(contributing factors, etc)using results of the questionnaire.